Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
Lescot E, Sopkova-de Oliveira Santos J, Colloc'h N, Rodrigo J, Milazzo-Segalas I, Bureau R, Rault S, Proteins, 2008 Oct - link

3D-QSAR and docking studies of selective GSK-3beta inhibitors. Comparison with a thieno[2,3-b]pyrrolizinone derivative, a new potential lead for GSK-3beta ligands.
Lescot E, Bureau R, Sopkova-de Oliveira Santos J, Rochais C, Lisowski V, Lancelot JC, Rault S, J Chem Inf Model, 2005 May-Jun - link